Bayer stock surges on report it is open to glyphosate settlement.
A wave of lawsuits over the flagship herbicide batters Bayer after its mammoth takeover of US seeds and pesticides maker Monsanto for $63 billion last year, based on its active ingredient glyphosate.
0 Comments
Pfizer Nears Mylan Merger Deal
US pharmaceutical giant Pfizer is nearing a deal to merge its off-patent drugs business with generic drugmaker Mylan, The Wall Street Journal reported Saturday.